Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    29 April 2024

    Asimov achieves 10x improvement in lentiviral production, launches new stable cell line development service

    Stable lentiviral (LV) cell line development service achieves unconcentrated titers >1E9 TU/mL for therapeutic transgenes. Fully stable cell lines have all viral genes and transgene stably integrated, enabling biomanufacturing scalability and a more robust production process. T...

    29 April 2024

    Guardtech Group off to a stormer in 2024 as action-packed quarter one flies by

    Haverhill-based cleanroom design & build experts are working on more than 20 significant projects concurrently – an all-time high ...

    25 April 2024

    Registration open for our Scientific Conference in June

    We are excited to announce that you can now secure your spot for the 2nd NIHR BioResource Scientific Conference, taking place online on Wednesday 19 June 2024 from 9.30am to 12.30pm. ...

    25 April 2024

    Owlstone Medical secures $6.5 million to support development of breath-based diagnostics for infectious disease

    $5 million equity investment and initial $1.5 million grant funding committed by the Bill & Melinda Gates Foundation for development of breath-based diagnostic solutions to improve outcomes in the developing world Funding represents the first time the foundation has taken an equ...

    24 April 2024

    Sharing a free white paper to compare your IT support service

    Breathe Technology wanted to share some valuable insights with you regarding the changing landscape of IT support for businesses and schools like yours. Our Managing Director recently penned a white paper outlining the shift from reactive break-fix models to proactive Full-Service MSP&n...

    19 April 2024

    Sphere Fluidics appoints Edward Rayner as Non-Executive Director

    Ed Rayner joins Sphere Fluidics as new board member to strengthen the Company’s strategic vision and ambition for commercial growth. ...

    23 April 2024

    CN Bio raises $21 million USD in first close of Series B investment round

    Bayland Capital and founding shareholder, CN Innovations Holdings Ltd, to invest $10M and $5.5M, respectively Investment will expand product development and scaling of the organization to meet increased demand for Organ-on-a-Chip (OOC) solutions Cambridge, UK - CN Bio, a leadi...

    23 April 2024

    Calluna Pharma appoints Margrethe Sørgaard as Senior Vice President of Clinical Operations and Pharmacovigilance

    First senior executive appointment made following Company launch to oversee strategic development of clinical programs ...

    19 April 2024

    Navigating payer challenges in rare disease

    Clinical and economic evidence generation across rare diseases is challenging due to intrinsic disease characteristics, misalignment on treatment costs, and inadequate traditional evaluation frameworks. Therefore, rare disease products face unique payer challenges, which need to be comp...

    22 April 2024

    Sable&Hawkes deliver new website for Granta Veterinary Specialists

    As part of a wider brand identity for our client Granta Veterinary Specialists – Sable&Hawkes, working with Pick Digital, have delivered a new corporate website. ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 147
    • Page 148
    • Current page 149
    • Page 150
    • Page 151
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS